Quantitative Measurement of Disc Asymmetry in Glaucoma
Principal Investigator
Christopher Girkin, MD
University of Alabama at Birmingham
Birmingham, AL, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
G2000007
Summary
Dr. Girkin hopes to determine whether a new technology for analyzing the optic nerve can be used to measure glaucomatous damage. This technology, known as confocal scanning laser ophthalmoscopy (CSLO), has the potential to allow for earlier diagnosis and to more accurately assess the progression of the disease. The quantitative aspect of currently used techniques is limited because of the normal variations in optic disc structure that occur even in a healthy population. However, structural differences between the two eyes in a healthy individual appear to be small, and Dr. Girkin is seeking to determine if measuring these differences with CSLO can be used to control for normal variability. In other words, he will determine the amount of asymmetry in optic disc structure in healthy individuals and determine if there is significantly greater asymmetry between the eyes of glaucoma patients or patients with high intraocular pressure. This is possible because even though glaucoma typically occurs in both eyes, it often progresses more quickly in one eye than in the other.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Arizona Board of Regents, University of Arizona
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Arizona Board of Regents, University of Arizona
National Glaucoma Research
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California